4.6 Article

Extended Follow-Up of Unruptured Intracranial Aneurysms Detected by Presymptomatic Screening in Patients with Autosomal Dominant Polycystic Kidney Disease

期刊

出版社

AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.09731110

关键词

-

资金

  1. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [DK058816, DK090728]

向作者/读者索取更多资源

Background and objectives Autosomal dominant polycystic kidney disease (ADPKD) patients have an increased risk for intracranial aneurysms (IAs). The importance of screening for unruptured IAs (UIAs) depends on their risks for growth and rupture. Design, setting, participants, & measurements ADPKD patients with UIAs found by presymptomatic screening with magnetic resonance angiography (MRA) during 1989 to 2009 were followed initially at 6 months and annually, and less frequently after demonstration of stability. Results Forty-five saccular aneurysms were detected in 38 patients from 36 families. Most were small (median diameter 3.5 mm) and in the anterior circulation (84%). Median age at diagnosis was 49 years. During cumulative imaging follow-up of 243 years, one de novo UIA was detected and increased in size from 2 to 4.4 mm over 144 months and two UIAs grew from 4.5 to 5.9 mm and 4.7 to 6.2 mm after 69 and 184 months, respectively. Seven patients did not have imaging follow-up. No change was detected in the remaining 28 patients. During cumulative clinical follow-up of 316 years, no aneurysm ruptured. Five patients died from unrelated causes and two were lost to follow-up after 8 and 120 months. Three patients underwent surgical clipping. Conclusions Most UIAs detected by presymptomatic screening in ADPKD patients are small and in the anterior circulation. Growth and rupture risks are not higher than those of UIAs in the general population. These data support very selective screening for UIAs in ADPKD patients, and widespread screening is not indicated. Clin J Am Soc Nephrol 6: 1274-1285, 2011. doi: 10.2215/CJN.09731110

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Urology & Nephrology

Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease

Mireille El Ters, Pengcheng Lu, Jonathan D. Mahnken, Jason R. Stubbs, Shiqin Zhang, Darren P. Wallace, Jared J. Grantham, Arlene B. Chapman, Vicente E. Torres, Peter C. Harris, Kyongtae Ty Bae, Douglas P. Landsittel, Frederic F. Rahbari-Oskoui, Michal Mrug, William M. Bennett, Alan S. L. Yu

Summary: In ADPKD patients, higher baseline FGF23 levels were associated with faster rates of total kidney volume increase and decline in glomerular filtration rate, as well as increased risk of disease progression and adverse outcomes. FGF23 serves as an early prognostic biomarker with additive value in guiding the treatment and management of ADPKD patients.

KIDNEY INTERNATIONAL REPORTS (2021)

Article Urology & Nephrology

Characteristics of Patients with End-Stage Kidney Disease in ADPKD

Shehbaz S. Shukoor, Lisa E. Vaughan, Marie E. Edwards, Sravanthi Lavu, Timothy L. Kline, Sarah R. Senum, Yaman Mkhaimer, Ghaith Zaatari, Maria V. Irazabal, Reem Neal, Marie C. Hogan, Ziad M. Zoghby, Peter C. Harris, Vicente E. Torres, Fouad T. Chebib

Summary: This study characterized genotypic and phenotypic attributes of ADPKD patients at end-stage kidney disease (ESKD). The findings showed that kidney volume at ESKD decreases with advancing age, especially in women. Different characteristics were observed in patients with ESKD onset at different ages, suggesting potential underlying mechanisms leading to ESKD differ between younger and older individuals.

KIDNEY INTERNATIONAL REPORTS (2021)

Article Urology & Nephrology

Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy

Fouad T. Chebib, Vicente E. Torres

Summary: ADPKD is the most common inherited cause of kidney failure, and predicting which patients will progress rapidly to kidney failure is essential. Various factors have been studied as prognostic markers, with age-adjusted TKV and the drug tolvaptan being key in clinical management. Individualized approaches and ongoing clinical trials aim to identify patients at risk of rapid progression and provide targeted treatment.

AMERICAN JOURNAL OF KIDNEY DISEASES (2021)

Article Urology & Nephrology

The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1RC/RC mouse model of autosomal dominant polycystic kidney disease

Jennifer Arroyo, Diana Escobar-Zarate, Harrison H. Wells, Megan M. Constans, Ka Thao, Jessica M. Smith, Cynthia J. Sieben, Madeline R. Martell, Timothy L. Kline, Maria Irazabal, Vicente E. Torres, Katharina Hopp, Peter C. Harris

Summary: ADPKD, primarily caused by mutations in PKD1 or PKD2, leads to progressive kidney cyst development and failure. Genetic background plays a significant role in influencing disease severity and progression in mouse models, with different strains showing variability in disease severity and progression rates.

KIDNEY INTERNATIONAL (2021)

Article Urology & Nephrology

Per-Treatment Post Hoc Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKD

Andrew J. Mallett, Ronald D. Perrone, Gopala Rangan, Carmel Hawley, Ragada El-Damanawi, Thomas F. Hiemstra, Carolina Townsend Arellano, Jennifer Lee, Vicente E. Torres

Summary: Post hoc analyses of completers in TEMPO 3:4 and REPRISE trials showed that the treatment effect of tolvaptan was similar in both trials, indicating that the greater treatment effect in REPRISE was not due to higher completion rates.

KIDNEY INTERNATIONAL REPORTS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Semantic Instance Segmentation of Kidney Cysts in MR Images: A Fully Automated 3D Approach Developed Through Active Learning

Adriana V. Gregory, Deema A. Anaam, Andrew J. Vercnocke, Marie E. Edwards, Vicente E. Torres, Peter C. Harris, Bradley J. Erickson, Timothy L. Kline

Summary: Total kidney volume (TKV) is a key imaging biomarker for monitoring disease progression and classifying ADPKD patients, but similar TKVs can lead to drastically different cystic presentations. A 3D semantic instance cyst segmentation algorithm was developed for kidneys in MR images to quantify these cystic differences effectively.

JOURNAL OF DIGITAL IMAGING (2021)

Article Urology & Nephrology

The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial

Judith E. Heida, Ron T. Gansevoort, Vicente E. Torres, Olivier Devuyst, Ronald D. Perrone, Jennifer Lee, Hui Li, John Ouyang, Arlene B. Chapman

Summary: This study investigated the effects of tolvaptan on blood pressure in patients with autosomal dominant polycystic kidney disease over a 3-year period. The results showed that long-term treatment with tolvaptan gradually lowered blood pressure compared with placebo, with significant reductions in systolic and diastolic blood pressure after 3 years of treatment. However, these differences leveled off at follow-up 3 weeks after discontinuation of the study medication.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Urology & Nephrology

Functional megalin is expressed in renal cysts in a mouse model of adult polycystic kidney disease

Marlene L. Nielsen, Mia C. Mundt, Dorte L. Lildballe, Maria Rasmussen, Lone Sunde, Vicente E. Torres, Peter C. Harris, Henrik Birn

Summary: The study on ADPKD mouse model revealed a pattern of megalin expression and endocytic function in cysts, suggesting potential drug targeting through megalin-mediated endocytosis in cysts.

CLINICAL KIDNEY JOURNAL (2021)

Article Genetics & Heredity

Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype

Sarah R. Senum, Ying (Sabrina) M. Li, Katherine A. Benson, Giancarlo Joli, Eric Olinger, Sravanthi Lavu, Charles D. Madsen, Adriana V. Gregory, Ruxandra Neatu, Timothy L. Kline, Marie -Pierre Audrezet, Patricia Outeda, Cherie B. Nau, Esther Meijer, Hamad Ali, Theodore I. Steinman, Michal Mrug, Paul J. Phelan, Terry J. Watnick, Dorien J. M. Peters, Albert C. M. Ong, Peter J. Conlon, Ronald D. Perrone, Emilie Cornec-Le Gall, Marie C. Hogan, Vicente E. Torres, John A. Saver, Peter C. Harris

Summary: This study identifies a link between the IFT140 gene and autosomal dominant polycystic kidney disease (ADPKD). The monoallelic variation of IFT140 is associated with mild PKD phenotype, while the biallelic variation is linked to a syndromic ciliopathy. The findings also suggest that the monoallelic IFT140 variation is relatively common among cystic kidney disease patients.

AMERICAN JOURNAL OF HUMAN GENETICS (2022)

Letter Urology & Nephrology

PKD1 Compared With PKD2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies

Cortney Steele, Zhiying You, Berenice Y. Gitomer, Godela M. Brosnahan, Kaleab Z. Abebe, William E. Braun, Arlene B. Chapman, Peter C. Harris, Ronald D. Perrone, Theodore I. Steinman, Vicente E. Torres, Alan S. L. Yu, Michel Chonchol, Kristen L. Nowak

KIDNEY INTERNATIONAL REPORTS (2022)

Article Urology & Nephrology

Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease

Kyongtae T. Bae, Cheng Tao, Robert Feldman, Alan S. L. Yu, Vicente E. Torres, Ronald D. Perrone, Arlene B. Chapman, Godela Brosnahan, Theodore I. Steinman, William E. Braun, Michal Mrug, William M. Bennett, Peter C. Harris, Avantika Srivastava, Douglas P. Landsittel, Kaleab Z. Abebe

Summary: This study aimed to evaluate the associations of polycystic liver progression with other disease progression variables and classify liver progression on the basis of patient's age, height-adjusted liver cystic volume, and height-adjusted liver volume. The use of height-adjusted liver cystic volume showed greater separations in volumetric progression of polycystic liver disease.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Urology & Nephrology

Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease

Xiaofang Wang, Li Jiang, Ka Thao, Caroline R. Sussman, Timothy LaBranche, Michael Palmer, Peter C. Harris, G. Stanley McKnight, Klaus P. Hoeflich, Stefanie Schalm, Vicente E. Torres

Summary: Upregulation of cAMP-dependent and cAMP-independent PKA signaling promotes cystogenesis in polycystic kidney disease (PKD). Activation of PKA-I promotes cystogenesis, while its inhibition prevents cyst formation. Inhibition of PKA activity can directly and/or indirectly inhibit multiple pro-proliferative pathways and is protective in vivo.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Cell Biology

Renal Ischemia Induces Epigenetic Changes in Apoptotic, Proteolytic, and Mitochondrial Genes in Swine Scattered Tubular-like Cells

Kamalnath S. Rajagopalan, Logan M. Glasstetter, Xiang-Yang Zhu, Roman Thaler, Hui Tang, Kyra L. Jordan, Ishran M. Saadiq, Sandra M. Herrmann, Alejandro R. Chade, Maria Irazabal, Lilach O. Lerman, Alfonso Eirin

Summary: This study found that renal artery stenosis can lead to epigenetic changes in renal tubular cells and affect cellular function.
Article Urology & Nephrology

Asymptomatic Pyuria as a Prognostic Biomarker in Autosomal Dominant Polycystic Kidney Disease

Brian E. Jones, Yaman G. Mkhaimer, Laureano J. Rangel, Maroun Chedid, Phillip J. Schulte, Alaa K. Mohamed, Reem M. Neal, Dalia Zubidat, Amarjyot K. Randhawa, Christian Hanna, Adriana Gregory, Timothy L. Kline, Ziad M. Zoghby, Sarah R. Senum, Peter C. Harris, Vicente E. Torres, Fouad T. Chebib

Summary: The study found that asymptomatic pyuria (AP) is associated with kidney failure and faster decline in kidney function, serving as a prognostic biomarker for the rate of disease progression in autosomal dominant polycystic kidney disease (ADPKD).

KIDNEY360 (2022)

Article Urology & Nephrology

Congenital Heart Disease in Adults with Autosomal Dominant Polycystic Kidney Disease

Maroun Chedid, Christian Hanna, Ghaith Zaatari, Yaman Mkhaimer, Prajwal Reddy, Laureano Rangel, Dalia Zubidat, Daniel-Hasan Nabil Kaidbay, Maria V. Irazabal, Heidi M. Connolly, Sarah R. Senum, Charles D. Madsen, Marie C. Hogan, Ziad Zoghby, Peter C. Harris, Vicente E. Torres, Jonathan N. Johnson, Fouad T. Chebib

Summary: This study observed a higher frequency of CHD in ADPKD patients compared to the general population. Although only PKD1 pathogenic variants were identified, further research is needed to confirm this association and understand the role of polycystins in cardiac and vascular development.

AMERICAN JOURNAL OF NEPHROLOGY (2022)

暂无数据